🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess secukinumab high dose (every 2 weeks...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-06-25
Trial ID
NCT03504852
Treatments Being Tested
Psoriasis is a chronic inflammatory skin disease characterized by scaly ind...
Status
Completed
Location
South Valley Hospitals
Start Date
2024-12-01
Trial ID
NCT06729463
Treatments Being Tested
The purpose of the study is to determine whether, in patients with moderate...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-07
Trial ID
NCT00941031
This study assessed efficacy of secukinumab, compared to ustekinumab, in pa...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-26
Trial ID
NCT02074982
Treatments Being Tested
Biologics such as secukinumab are currently the most effective treatment op...
Status
Completed
Location
AZ Maria Middelares
Start Date
2018-03-22
Trial ID
NCT04080661
Treatments Being Tested
The main objective of this study is to evaluate the efficacy and safety of ...
Status
Completed
Location
Advanced Research Associates - Glendale /ID# 204335
Start Date
2018-05-08
Trial ID
NCT03478787
Treatments Being Tested
Atopic Dermatitis, also known as atopic eczema, or eczema, is a common skin...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2015-11
Trial ID
NCT02594098
Treatments Being Tested
The purpose of this study was to demonstrate efficacy of autoinjector admin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10-17
Trial ID
NCT01636687
Treatments Being Tested
This study is a multicenter, randomized, double-blind, parallel-arm, Phase ...
Status
Completed
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2022-10-26
Trial ID
NCT05377944
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested